Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Caffeine and sodium benzoate injection solution vial |
Is a |
Product containing caffeine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
Is a |
Product containing caffeine in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Caffeine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bronchodilator |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Caffeine and sodium benzoate injection |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Xanthine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
Is a |
Caffeine- and sodium benzoate-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Stimulant (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sodium benzoate (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sodium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phosphodiesterase inhibitor |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
Has manufactured dose form |
Injection (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Xanthine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sodium electrolyte |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
Is a |
Product containing caffeine in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
Is a |
Sodium-containing product in parenteral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
Is a |
Product containing sodium benzoate (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Caffeine and sodium benzoate injection solution vial |
Has manufactured dose form |
Injection solution (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|